SARS
SARS 相关产品(85)
- GC46895Aurintricarboxylic Acid (ammonium salt)CAS: 569-58-4
A protein synthesis inhibitor with diverse biological activities
- GC47452Imatinib-d3CAS: 1134803-18-1纯度: >99.00%
An internal standard for the quantification of imatinib
- GC49165GS-441524 tris-isobutyryl esterCAS: 2563617-99-0纯度: >98.00%
An orally bioavailable prodrug form of GS-443902
- GC49357N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl esterCAS: 1354823-36-1纯度: >98.00%
A synthetic intermediate
- GC61240Remdesivir O-desphosphate acetonide impurityCAS: 1191237-80-5纯度: >99.50%
An intermediate in the synthesis of remdesivir
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC19920 | Ensitrelvir | 2647530-73-0 | >99.00% | |
An inhibitor of SARS-CoV-2 M pro | ||||
| GC39318 | DSHS00884 | 675104-49-1 | >98.00% | |
DSHS00884 是有效的人乳头瘤病毒 E6 抑制剂，IC50 为 10 μM。 | ||||
| GC46895 | Aurintricarboxylic Acid (ammonium salt) | 569-58-4 | - | |
A protein synthesis inhibitor with diverse biological activities | ||||
| GC47452 | Imatinib-d3 | 1134803-18-1 | >99.00% | |
An internal standard for the quantification of imatinib | ||||
| GC48036 | Remdesivir-d4 | 2738376-82-2 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48101 | SSAA09E1 | 433212-75-0 | >98.00% | |
A SARS-CoV entry inhibitor | ||||
| GC49165 | GS-441524 tris-isobutyryl ester | 2563617-99-0 | >98.00% | |
An orally bioavailable prodrug form of GS-443902 | ||||
| GC49357 | N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl ester | 1354823-36-1 | >98.00% | |
A synthetic intermediate | ||||
| GC50716 | K 22 | 2141978-86-9 | >98.00% | |
An antiviral agent | ||||
| GC61240 | Remdesivir O-desphosphate acetonide impurity | 1191237-80-5 | >99.50% | |
An intermediate in the synthesis of remdesivir | ||||
| GC92121 | P9R (trifluoroacetate salt) | - | >95.00% | |
P9R (trifluoroacetate salt)是一种具有抗病毒活性的肽。 | ||||
| GP25163 | SARS Mosaic S(N) | - | - | |
SARS-Associated Coronavirus Spike Mosaic S (N) Recombinant | ||||
| GP25164 | SARS Mosaic S(M) | - | - | |
SARS-Associated Coronavirus Spike Mosaic S (M) Recombinant | ||||
| GP25165 | SARS Mosaic S(C) | - | - | |
SARS-Associated Coronavirus Spike Mosaic S(C) Recombinant | ||||
| GP25166 | SARS Core (340-390) | - | - | |
SARS-Associated Coronavirus Nucleocapsid Core Recombinant, (340-390 a.a) | ||||
| GP25167 | SARS Core (1-49) | - | - | |
SARS-Associated Coronavirus Nucleocapsid Core Recombinant, 1-49 a.a. | ||||
| GP25168 | SARS Core (1-49,192-220 a.a.) | - | - | |
SARS-Associated Coronavirus Nucleocapsid Core Recombinant | ||||
| GP25169 | SARS-CoV | - | - | |
SARS-CoV Nucleocapsid (422a.a) Recombinant | ||||
| GP25170 | SARS Matrix | - | - | |
SARS-Associated Coronavirus Matrix Recombinant | ||||
| GP25171 | SARS Envelope | - | - | |
SARS相关冠状病毒包膜重组体 | ||||
| GP25172 | CoV-229E | - | - | |
Coronavirus 229E Recombinant | ||||
| GP25173 | SARS MERS | - | - | |
SARS MERS Spike S1 Recombinant | ||||
| GP25174 | CoV-NL63 | - | - | |
Coronavirus NL63 Recombinant | ||||
| GP26113 | ACE Human | - | - | |
ACE Human produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 1235 amino acids (30-1256 a | ||||